Search Results
Oct 14, 2025, 17:31 ET Anaplastic Astrocytoma Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2025-2034) | DelveInsight
Therapeutics, Laminar Pharmaceuticals, MedImmune, DNAtrix, Immunomic Therapeutics, Imvax, MimiVax, CNS Pharmaceuticals, Epitopoietic Research Corporation (ERC), Istari Oncology, SonALAsense, Kintara Therapeutics, Bristol Myers Squibb, Medicenna Therapeutics, BioMimetix, Eisai, Merck Sharp & Dohme, Kazia
More news about: DelveInsight Business Research, LLP
Oct 14, 2025, 14:22 ET Eightco Holdings Inc. ($ORBS) 對 Mythical Games 進行策略投資，加速遊戲中的人工驗證和數碼身份
Linden 領導，並擁有不斷增長的領先特許經營權組合（包括 NFL Rivals、Pudgy Penguins 的 Pudgy Party 和 FIFA Rivals），而成為 Web3 遊戲與數碼擁有權的先驅。該公司計劃與 Worldchain 整合，而擴展自身市場產品。Worldchain 是兼容 ERC-20 的區塊鏈，專為「人類證明」(PoH) 驗證和單點登錄而建。這標誌向安全兼可驗證的遊戲基礎設施，邁進重要一步。 Mythical Games 與 Worldchain 和 World ID 的擴展將實現遊戲資產、錢包和身份之間的無縫互通性。這予玩家驗證數碼資產擁有權，同時減少欺詐和改善用戶遊戲開始。Eightco、Mythical
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 14, 2025, 12:43 ET Eightco Holdings Inc. ($ORBS) doet een strategische investering in Mythical Games om menselijke verificatie en digitale identiteit in games te versnellen
Rivals, Pudgy Penguins' Pudgy Party en FIFA Rivals. Het bedrijf is van plan om haar marktplaatsproduct uit te breiden en te integreren met Worldchain, een ERC-20-compatibele blockchain die voor PoH-verificatie (Proof of Human) en unieke sign-on is gebouwd, wat een grote stap vooruit betekent in veilige, verifieerbare
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 14, 2025, 12:29 ET Eightco Holdings Inc. ($ORBS) realiza una inversión estratégica en Mythical Games
Penguins y FIFA Rivals. La empresa tiene previsto ampliar su producto de mercado para integrarlo con Worldchain, una cadena de bloques compatible con ERC-20 creada para la verificación Proof of Human (PoH) y el inicio de sesión único, lo que supone un importante paso adelante en la infraestructura de juegos
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 14, 2025, 08:01 ET Prestige Wealth Inc. Signs and Closes Approx. $150 Million Financing for Aurelion Treasury; Initiating NASDAQ's First Tether Gold Treasury; Prestige Wealth Inc. (NASDAQ: AURE) Plans to be Renamed to Aurelion Inc., Subject to Approvals
offered by TG Commodities, S.A. de C.V. One full XAU₮ token represents one troy fine ounce of gold on a London Good Delivery bar. XAU₮ is available as an ERC-20 token on the Ethereum blockchain. The token can be traded or moved easily 24/7. XAU₮ allocated gold is identifiable with a unique serial number, purity,
More news about: Prestige Wealth Inc.
Oct 14, 2025, 08:00 ET Prestige Wealth Inc. (NASDAQ: AURE) Completes $134 Million Purchase of Tether Gold (XAU₮)
Commodities, S.A. de C.V. One full XAU₮ token represents one troy fine ounce of gold on a London Good Delivery bar. XAU₮ is available as an ERC-20 token on the Ethereum blockchain. The token can be traded or moved easily 24/7. XAU₮ allocated gold is identifiable
More news about: Prestige Wealth Inc.
Oct 13, 2025, 08:30 ET Eightco Holdings Inc. ($ORBS) Makes Strategic Investment into Mythical Games to Accelerate Human Verification and Digital Identity in Gaming
including NFL Rivals, Pudgy Penguins' Pudgy Party, and FIFA Rivals. The company plans to expand its marketplace product to integrate with Worldchain, an ERC-20-compatible blockchain built for Proof of Human (PoH) verification and single sign-on, marking a major step forward in secure, verifiable gaming infrastructure.
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 13, 2025, 08:30 ET Eightco Holdings Inc. ($ORBS) Makes Strategic Investment into Mythical Games to Accelerate Human Verification and Digital Identity in Gaming
including NFL Rivals, Pudgy Penguins' Pudgy Party, and FIFA Rivals. The company plans to expand its marketplace product to integrate with Worldchain, an ERC-20-compatible blockchain built for Proof of Human (PoH) verification and single sign-on, marking a major step forward in secure, verifiable gaming infrastructure.
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 08, 2025, 18:49 ET Recall Announces Launch of ERC-20 Token on Base October 15
public on major exchanges starting Oct. 15, with airdrop access for select early supporters. RECALL, launching on Base as an ERC-20 token which can be bridged to any other network, enables the world to coordinate, rank, and reward quality AI aligned to their needs,
More news about: Recall
Oct 08, 2025, 08:30 ET Allspring Closed-End Funds Announce Changes to their Portfolio Management Teams
8, 2025 /PRNewswire/ -- The Allspring Income Opportunities Fund (NYSE America: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), the Allspring Utilities and High Income Fund (NYSE American: ERH), and the Allspring Global Dividend Opportunities Fund (NYSE: EOD) announced today
More news about: Allspring Global Investments
Sep 26, 2025, 08:30 ET Allspring Closed-End Funds Declare Monthly Distributions
2025 /PRNewswire/ -- The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and the Allspring Utilities and High Income Fund (NYSE American: ERH) have each announced a distribution.
More news about: Allspring Global Investments
Sep 25, 2025, 10:49 ET Fractal Bitcoin Launches Wrapped FB (WFB) on Ethereum
Sept. 25, 2025 /PRNewswire/ -- Fractal Bitcoin today announced Wrapped Fractal Bitcoin (WFB), an ERC-20 representation of the Fractal Bitcoin token (FB) on Ethereum. The introduction of WFB marks Fractal Bitcoin's
More news about: Fractal Bitcoin
Sep 24, 2025, 09:00 ET Lanzan estudio que mejora la sobrevida de pacientes en diálisis.
Santa Carmen: Líder en salud renal en México Con más de una década de experiencia en la atención de pacientes con ERC, Médica
More news about: Médica Santa Carmen
Sep 22, 2025, 07:00 ET Liquid Staked 'mXRP' Launches, Powered by Midas and Axelar: Tokenized Exposure to Onchain Yield for the XRP Ecosystem
axelar.network. About Midas Midas is a tokenization platform building institutional-grade financial products for the open web. Its ERC-20 tokens are structured to track dedicated strategies with verifiable onchain performance, combining TradFi-grade standards with DeFi composability.
More news about: Axelar
Sep 18, 2025, 17:31 ET NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight
Therapeutics, Laminar Pharmaceuticals, MedImmune, DNAtrix, Immunomic Therapeutics, Imvax, MimiVax, CNS Pharmaceuticals, Epitopoietic Research Corporation (ERC), Istari Oncology, SonALAsense, Kintara Therapeutics, Bristol Myers Squibb, Medicenna Therapeutics, BioMimetix, Eisai, Merck Sharp & Dohme, Kazia
More news about: DelveInsight Business Research, LLP